title: Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma.
authors.affiliation: West Penn Allegheny Oncology Network, Pittsburgh, Pennsylvania.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Shelledy
authors.affiliation: West Penn Allegheny Oncology Network, Pittsburgh, Pennsylvania.
authors.forename: Danielle
authors.initials: D
authors.lastname: Roman